d 57.9 (s). 13CM1HN NMR (101 MHz, C D , 20 ¡C): d 19.7
J
\ 13.4, 6.3 Hz, 1H, OCH CHOCH ), 4.58 (dd, J
\
6
6
HvH
2
2
HvH
[s, P(CHMe ) ], 20.5 [s, P(CHMe ) ], 26.3 [vt, J
\
13.4, 2.1 Hz, 1H, OCH CHOCH ). 31PM1HN NMR (121 MHz,
C D , 20 ¡C): d 56.33, 56.24 (AB pattern, 2J \ 220 Hz).
2 3
2 3
PvC
2
2
9.7 Hz, P(CHMe ) ], 41.3 [s, Ru2C(Me)OCH È],
2 3
2
6
6
PvP
71.3
[s,
Ru2C(Me)OCH È],
9.1 Hz, Ru2C(Me)OCH È].
288.8
(t,
2J
\
2
PvC
Rw uHCl(PPri ) (2C(Me)N(Me)C(Oz )CH ). Under Ar, 75 mg
2
3 2 3
(0.164 mmol) of RuHCl(PPri ) was charged in a Schlenk Ñask
and dissolved in 10 mL of benzene. V ia syringe, 18.6 lL (0.180
mmol) of N-methyl-N-vinylacetamide was added and the
solution stirred for 4 days. The benzene was removed to a N
trap and the purple solid was washed with pentane.
Drying
3 2
Preparation of 2-Ñuoroethyl vinyl ether: CH 2CH(OCH -
2
2
CH F). Under Ar, 1.85 g (11.5 mmol) of diethylamino sulfur
2
triÑuoride (DAST)29 was dissolved in 10 mL CH Cl . The
solution was cooled to [78 ¡C and 1.03 mL (11.5 mmol) of
ethylene glycol vinyl ether was added via syringe. The solution
was allowed to warm to room temperature and stirred for 1 h,
2
2
2
in
vacuo
yielded
40
mg
(45%)
of
Rw uHCl(PPri ) (2C(Me)N(Me)C(Oz )CH3). 1H NMR (400 MHz,
3 2
then cooled to 0 ¡C and the solvent removed to an N trap.
CD Cl , 20 ¡C): d [ 17.24 (t, 2J \ 26.2 Hz, 1H, RuH), 0.96
2
2
2
PvH
The product was then fractionally distilled, collecting the 79È
[dvt, J \ 3J \ 6.4 Hz, 18H, P(CHMe ) ], 1.28 [dvt,
PvH
\ 3J \ 6.4 Hz, 18H, P(CHMe ) ], 2.20 [s, 3H,
HvH 2 3
Ru2C(Me)NR ], 2.22È2.36 [m, 6H, P(CHMe ) ], 2.43 [s, 3H,
HvH
2 3
81 ¡C fraction (760 torr). Yield : approx. 500 mg (49%). 1H
J
PvH
NMR (300 MHz, C D , 20 ¡C):d 3.28 (dt, 3J \ 28.5 Hz,
6
6
FvH
2
2 3
3J \ 3.9 Hz, 2H, OCH CH F), 3.89 [dd, 3J \ 6.9 Hz,
N(Me)C(O)Me], 3.34 [s, 3H, N(Me)C(O)Me]. 31PM1HN NMR
HvH
2J \ 1.5 Hz, 1H, CH 2CH(OR)], 4.01 [dd, 3J \ 14.1
HvH HvH
Hz, 2J \ 1.5 Hz, 1H, CH 2CH(OR)], 4.06 (dt, 3J \ 47.7
HvH FvH
Hz, 3J \ 3.9 Hz, 2H, OCH CH F), 6.30 [dd, 3J \ 14.1
HvH HvH
Hz, 3J \ 6.9 Hz, 1H, CH 2CH(OR)]. 13CM1HN NMR (75.5
HvH
MHz, C D , 20 ¡C): d 67.0 (d, 2J \ 20.5 Hz, OCH CH F),
FvC
81.5 (d, 1J \ 171 Hz, OCH CH F), 86.1 [s, CH 2CH(OR)],
FvC
151.7 [s, CH 2CH(OR)]. 19F NMR (282 MHz, C D , 20 ¡C):
2
2
HvH
(162 MHz, CD Cl , 20 ¡C): d 50.4 (s). 13CM1HN NMR (101
2
2 2
MHz, CD Cl , [20 ¡C): d 18.7 [s, P(CHMe ) ], 19.4 [s,
2
2
2 3
2
2 3
P(CHMe ) ], 22.9 [s, N(Me)C(O)Me], 25.9 [vt, J \ 8.6
2
2
PvC
Hz, P(CHMe ) ], 34.7 [s, N(Me)C(O)Me], 40.9 [s,
2
2 3
Ru2C(Me)NR ], 174.7 [s, N(Me)C(O)Me], 265.3 (t, 2J
9.7 Hz, Ru2C). m (CH Cl , 25 ¡C) \ 1599 cm~1.
\
6
6
2
2
2
PvC
2
2
2
6 6
CO
2 2
2
d [224.8 (tt, 2J \ 47.7 Hz, 3J \ 28.5 Hz).
HvF HvF
RuHCl(PPri ) (2C(Me)Nw C(O)CH CH Cz H ). Under Ar,
3 2 2 2 2
240 mg (0.524 mmol) of RuHCl(PPri ) was charged in a
Schlenk Ñask and dissolved in 35 mL of benzene. V ia syringe,
60.0 lL (0.561 mmol) of 1-vinyl-2-pyrrolidinone was added
and the solution stirred for 2 days. The benzene was re-
moved to a liquid N trap and the purple solid was
washed with pentane. Drying in vacuo yielded 160 mg
3 2
RuHCl(PPri ) (2C(Me)OCH CH F). Under Ar, 10 mg
3 2
2
2
(0.022 mmol) of RuHCl(PPri ) was placed in an NMR tube in
3 2
C D . V ia syringe, 2.5 lL (0.022 mmol) of 2-Ñuoroethyl vinyl
6
6
ether was added and the NMR tube sealed. 1H, 19F, and
31PM1HN NMR spectra taken after 3 h revealed quantitative
conversion to RuHCl(PPri ) (2C(Me)OCH CH F). 1H NMR
2
(90% by 31PM1HN integration before workup) of
3 2
2
2
(300 MHz, C D , 20 ¡C): d [21.32 (t, 2J \ 21.6 Hz, 1H,
RuHCl(PPri ) (2C(Me)Nw C(O)CH Cz H CH ). 1H NMR (400
6
6
PvH
RuH), 1.12 [dvt, J \ 3J \ 6.3 Hz, 18H, P(CHMe ) ],
PvH HvH 2 3
3 2
2
2
2
2
MHz, CD Cl , 20 ¡C): d [19.56 (t, 2J \ 25.8 Hz, 1H,
2
PvH
RuH), 0.98 [dvt, J \ 3J \ 6.4 Hz, 18H, P(CHMe ) ],
PvH HvH 2 3
1.27 [dvt, J \ 3J \ 6.4 Hz, 18H, P(CHMe ) ], 2.01 [s,
PvH HvH 2 3
3H, Ru2C(Me)NR ], 2.23È2.37 [m, 6H, P(CHMe ) ], 2.32
2 3
(apparent quintet, 3J \ 7.5 Hz, 2H, NC(O)CH CH CH ),
HvH
2.52 [t, 3J \ 8.0 Hz, 2H, NC(O)CH CH CH ], 3.70 [t,
HvH
3J \ 7.0 Hz, 2H, NC(O)CH CH CH ]. 31PM1HN NMR
HvH
(162 MHz, CD Cl , 20 ¡C): d 49.3 (s). 13CM1HN NMR (101
1.25 [dvt, J \ 3J \ 6.3 Hz, 18H, P(CHMe ) ], 2.32È2.44
PvH
HvH
2 3
[m, 6H, P(CHMe ) ], 2.72 [s, 3H, Ru2C(Me)OR], 4.26 (dt,
2 3
2J \ 47.7 Hz, 3J \ 3.9 Hz, 2H, OCH CH F), 4.46 (dt,
FvH
FvH
HvH
2
2
2
2
2
3J \ 29.7 Hz, 3J \ 3.9 Hz, 2H, OCH CH F). 31PM1HN
HvH
2
2
2
2
NMR (121 MHz, C D , 20 ¡C): d 57.8 (s). 19F NMR (282
6
6
2
2
2
MHz, C D , 20 ¡C): d [224.1 (tt, 2J \ 47.7 Hz, 3J
HvF HF
\
6
6
2
2
29.7 Hz).
2
2
MHz, CD Cl , [ 20 ¡C): d 19.0 [s, P(CHMe ) ], 19.6 [s,
2 3
P(CHMe ) ], 22.1 [s, NC(O)CH CH CH ], 25.9 [vt, J
2 3 PvC
8.6 Hz, P(CHMe ) ], 29.7 [s, NC(O)CH CH CH ], 40.4 [s,
2 3
Ru2C(Me)NR ], 45.9 [s, NC(O)CH CH CH ], 180.2 [s,
2
2
RuHCl(PPri ) (2C(Me)OCH CH NEt ). Under Ar, 10 mg
\
3 2
2
2
2
2
2
2
2
(0.022 mmol) of RuHCl(PPri ) was placed in an NMR tube in
3 2
2
2
C D . V ia syringe, 4.1 lL (0.022 mmol) of 2-(diethylamino)
6
6
2
2
2
2
2
ethanol vinyl ether was added and the tube sealed. 1H and
31PM1HN NMR spectra taken after 90 min revealed quantitat-
ive conversion to RuHCl(PPri ) (2C(Me)OCH CH NEt ). 1H
NC(O)CH CH CH ], 261.5 (t, 2J \ 10.0 Hz, Ru2C).
PvC
2
2
2
m
(CH Cl , 25 ¡C) \ 1640 cm~1.
CO
2
3 2
2
2
2
NMR (400 MHz, C D , 20 ¡C): d [21.41 (brs, 1H, RuH), 0.96
RuHCl(PPri ) (CH 2CH–NC H O ). Under Ar, 100 mg
3 2 2 8 4 2
6
6
[t, 3J \ 7.2 Hz, 3H, N(CH CH ) ], 1.16 [dvt, J
HvH 3 2
3J \ 6.4 Hz, 18H, P(CHMe ) ], 1.29 [dvt, J \ 3J
HvH 2 3 PvH
\
\
(0.218 mmol) of RuHCl(PPri ) and 38 mg (0.218 mmol) of
vinyl phthalimide were mixed and then stirred 1.5 h at room
temperature. The solvent was removed and the product dried
2
PvH
HvH
3 2
6.4 Hz, 18H, P(CHMe ) ], 2.40È2.50 (m, 6H, P(CHMe ) ],
2 3
2 3
2.47 [q, 3J \ 7.2 Hz, 2H, N(CH CH ) ], 2.74 [s, 3H,
HvH 3 2
Ru2C(Me)OR], 2.77 (t, 3J \ 6.8 Hz, 2H, OCH CH NEt ),
HvH
4.54 (t, 3J \ 6.8 Hz, 2H, OCH CH NEt ). 31PM1HN NMR
HvH
(162 MHz, C D , 20 ¡C): d 56.4 (s).
in vacuo. Yield: quantitative. 1H NMR (400 MHz, THF-d ,
2
8
0 ¡C): d [20.83 (dd, 2J \ 15.6, 27.6 Hz, 1H, RuH), 1.10
2
2
2
PvH
[dvt,
J
\ 3J \ 7.6 Hz, 9H, P(CHMe ) ], 1.25 [m,
2
2
2
PvH
HvH
2 3
29H, P(CHMe ) ], 1.64 (brd, 1H,
CH 2CHÈNC H O ), 2.41 (dd, 1H, J \ 14.0, 4.4 Hz,
CH 2CHÈNC H O ), 2.74 [br s, 3H, P(CHMe ) ], 2.85 [brs,
J
\ 3.2 Hz,
6
6
2 3
HvH
2
2
8
4
2
HvH
RuHCl(PPri ) (2C(Me)OCH CHOCH ). Under Ar, 10 mg
3 2
2
2
8
4
2 3
2
2 3
(0.022 mmol) of RuHCl(PPri ) was placed in an NMR tube in
3H, P(CHMe ) ], 4.74 (ddd
È
apparent dt, 1H, J
3 2
HvH
C D . V ia syringe, 2.2 lL (0.022 mmol) of glycidyl vinyl ether
\ 14.6, 6.4 Hz, CH 2CHÈNC H O ), 7.82 (m, 4H,
6
6
2
8 4 2
(racemic) was added and the NMR tube sealed. 1H and
31PM1HN NMR spectra taken after 1 h revealed quantitative
conversion to RuHCl(PPri ) (2C(Me)OCH CHOCH ). 1H
CH 2CHÈNC H O ). 31PM1HN NMR (162 MHz, THF-d ,
2
8
4
2
8
0 ¡C): d 35.4, 57.9 (AX pattern, J \ 278 Hz). 13CM1HN NMR
PvP
(101 MHz, THF-d , [20 ¡C): d 19.5, 19.8, 20.16, 20.22 [s,
3 2
2
2
8
NMR (300 MHz, C D , 20 ¡C): d [21.41 (t, 2J \ 22.2 Hz,
P(CHMe ) ], 24.1 [d, J \ 11.1 Hz, P(CHMe ) ], 24.8 [d,
6
6
PvH
\ 3J \ 6.4 Hz, 18H,
HvH
2 3
PvC
2 3
1H, RuH), 1.15 [dvt,
J
J
J
\ 16.1 Hz, P(CHMe ) ], 29.8 (s, CH 2CHÈNC H O ),
PvH
PvC
2 3
2
8 4 2
P(CHMe ) ], 1.26 [dvt,
P(CHMe ) ], 2.22 (dd,
\ 3J \ 6.4 Hz, 18H,
HvH
60.2 (s, CH 2CHÈNC H O ), 124.1, 124.7, 129.1, 130.8, 135.4
2 3
2 3
PvH
2
8 4 2
J
\ 5.3, 2.3 Hz, 1H,
(s, CH 2CHÈNC H O aromatics; the peak at 135.4 is over
twice as large as the others and arises from two signals with
coincidental overlap), 167.0, 176.6 (s, CH 2CHÈNC H O
carbonyls).
HvH
2
8 4 2
OCH CHOCH ), 2.30 (apparent t,
J
\ 4.4 Hz, 1H,
2
2
2
2
HvH
OCH CHOCH ), 2.35È2.45 [m, 6H, P(CHMe ) ], 2.72 [s, 3H,
2 3
Ru2C(Me)OR], 3.00 (m, 1H, OCH CHOCH ), 4.34 (dd,
2
8 4 2
2
2
24
New J. Chem., 2000, 24, 9È26